# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-011598
Filing Date
2025-08-05
Accepted
2025-08-05 09:00:44
Documents
55
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1415332
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 20057
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 20074
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 8292
| Complete submission text file | 0001493152-25-011598.txt |  | 5267285

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | imnn-20250630.xsd | EX-101.SCH | 34941
6 | XBRL CALCULATION FILE | imnn-20250630_cal.xml | EX-101.CAL | 39110
7 | XBRL DEFINITION FILE | imnn-20250630_def.xml | EX-101.DEF | 121372
8 | XBRL LABEL FILE | imnn-20250630_lab.xml | EX-101.LAB | 336326
9 | XBRL PRESENTATION FILE | imnn-20250630_pre.xml | EX-101.PRE | 245245
57 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 755781

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 251183131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)